Tablets Globalcare Private Limited

Tablets Globalcare Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U24110TN2018PTC124933 Incorporated 28 September 2018 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹39.17 Lakh
▼ 61% YoY
Net loss · FY 2025
₹13.53 Lakh
Net margin -34.5%
EBITDA · FY 2025
-₹6.53 Lakh
EBITDA margin -16.7%
Authorised capital
₹2.5 Cr
Registered with MCA
Paid-up capital
₹1.21 Cr
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
5
As per MCA filings
Active GSTINs
1
GST registered

About Tablets Globalcare Private Limited

Data last updated:

Tablets Globalcare Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 September 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24110TN2018PTC124933. Its GSTIN is 33AAGCT9453K1ZW (Tamil Nadu).

The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹1.21 Cr. It is led by directors including Dhruv Narayan Purohit and Balamurugan Rengasamy.

Its last annual general meeting (AGM) was held on 20 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Block No 6A R.A.Building 2nd Floor Old No. 19 New No.72 Marshalls Road Chennai – 600, 008, Tamil Nadu, India – 600008.

As per the financials filed for FY 2025, the company reported a revenue of ₹39.17 Lakh, a decline of 61% compared to the previous year. For the same year it recorded a net loss of ₹13.53 Lakh (net margin -34.5%) and EBITDA of -₹6.53 Lakh (EBITDA margin -16.7%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 188% over five years.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tabletsglobal.com.

Company details

CIN U24110TN2018PTC124933
Registration Number 124933
Incorporation Date 28 September 2018
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 20 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Tablets Globalcare Private Limited's registered office is in Chennai, Tamil Nadu. Its website is tabletsglobal.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Block No 6A R.A.Building 2nd Floor Old No. 19 New No.72 Marshalls Road Chennai – 600, 008, Tamil Nadu, India – 600008
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Tablets Globalcare Private Limited, buy the company report.

Comprehensive company report
Tablets Globalcare Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Tablets Globalcare is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Tablets Globalcare Private Limited, buy the company report.

Financials of Tablets Globalcare Private Limited

FY 2025 filings available

Tablets Globalcare Private Limited reported revenue of ₹39.17 Lakh (down 61% YoY) for FY 2025.

Revenue · FY 2025
₹39.17 Lakh ▼ 61%
Net loss · FY 2025
₹13.53 Lakh margin -34.5%
EBITDA · FY 2025
-₹6.53 Lakh margin -16.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 61%
3 years · compounded
▲ 10%
5 years · compounded
▲ 188%
EBITDA CAGR growth
1 year
▲ 75%
3 years · compounded
▼ 40%
5 years · compounded
▲ 16%

Revenue fell 61% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 188%. EBITDA rose 75% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹6.53 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹13.53 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-16.7%
Net Profit Margin-34.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Tablets Globalcare Private Limited, buy the company report.

Board of directors of Tablets Globalcare Private Limited

Tablets Globalcare has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Dhruv Narayan PurohitDirector28 Sep 20188 Years 0 MonthsCurrent
Balamurugan RengasamyDirector21 Oct 20197 Years 0 MonthsCurrent
Sathish ThiruvengadamDirector21 Oct 20197 Years 0 MonthsCurrent
Juma VenkateshDirector21 Oct 20197 Years 0 MonthsCurrent
Venkatesh Rajendra ArakontalaDirector21 Oct 20197 Years 0 MonthsCurrent

Auditor

Tablets Globalcare Private Limited is audited by KOCHAR S AND ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
KOCHAR S AND ASSOCIATESFY 2023024590S

Shareholding

The shareholding of Tablets Globalcare Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Tablets Globalcare Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Tablets Globalcare Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Tablets Globalcare has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
33AAGCT9453K1ZWTamil NaduActive02 Jan 2019

To see the full GST registrations and return filing status of Tablets Globalcare Private Limited, buy the company report.

Recent activity

Tablets Globalcare Private Limited has 10 board changes on record since 2018: 5 appointments and 5 cessations. The latest: Balamurugan Rengasamy ceased to be Additional Director on 07 Sep 2020.

AGM
Tablets Globalcare Private Limited last Annual general meeting of members was held on 20 Sep 2025 as per latest MCA records.
Filing
Tablets Globalcare Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Ceased
Balamurugan Rengasamy ceased to be Additional Director.
Ceased
Juma Venkatesh ceased to be Additional Director.
Ceased
Sathish Thiruvengadam ceased to be Additional Director.
Ceased
Venkatesh Rajendra Arakontala ceased to be Additional Director.
Appointed
Balamurugan Rengasamy was appointed as Director.
Appointed
Juma Venkatesh was appointed as Director.
Appointed
Sathish Thiruvengadam was appointed as Director.
Ceased
Venkata Krishna Murty Ponnapalli ceased to be Director.
Appointed
Venkatesh Rajendra Arakontala was appointed as Director.
Appointed
Dhruv Narayan Purohit was appointed as Director.

1 earlier event is in the company report.

Frequently asked questions

Tablets Globalcare is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 September 2018 (8+ years old) and is registered under CIN U24110TN2018PTC124933.

Tablets Globalcare has 5 current directors:

The latest financial statements of Tablets Globalcare on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 20 September 2025. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Tablets Globalcare is 33AAGCT9453K1ZW, registered in Tamil Nadu.

The CIN (Corporate Identification Number) of Tablets Globalcare is U24110TN2018PTC124933. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Tablets Globalcare was incorporated on 28 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chennai.

Balamurugan Rengasamy ceased to be Additional Director on 07 Sep 2020. Juma Venkatesh ceased to be Additional Director on 07 Sep 2020. Sathish Thiruvengadam ceased to be Additional Director on 07 Sep 2020. Tablets Globalcare has 10 board changes on record in total.

Tablets Globalcare can be reached through the website tabletsglobal.com. Its registered office is in Chennai, Tamil Nadu, India.

The registered office of Tablets Globalcare is at Block No 6A R.A.Building 2nd Floor Old No. 19 New No.72 Marshalls Road Chennai – 600, 008, Tamil Nadu, India – 600008.

Tablets Globalcare operates in the pharma industry, in the pharmaceutical retailers and distributors segment.